Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion

Candida albicans Multilocus Sequence Typing Clade I Contributes to the Clinical Phenotype of Vulvovaginal Candidiasis Patients

(2022) Yuxia Zhu et al.   Frontiers in Medicine

Combining Miconazole and Domiphen Bromide Results in Excess of Reactive Oxygen Species and Killing of Biofilm Cells

(2021) Jana Tits et al.   Frontiers in Cell and Developmental Biology

Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)

(2021) Alex Farr et al.   MYCOSES

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

(2021) Ahmed Gamal et al.   Frontiers in Cellular and Infection Microbiology

Immune Sensing of Candida albicans

(2021) Ebrima Bojang et al.   Journal of Fungi

Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020)

(2021) Alex Farr et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Fungal Toxins and Host Immune Responses

(2021) Rhys Brown et al.   Frontiers in Microbiology

Evidence‐based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis

(2021) Moira Bradfield Strydom et al.   AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis

(2021) D. Moreira et al.   MYCOPATHOLOGIA

Candida glabrata: Pathogenicity and Resistance Mechanisms for Adaptation and Survival

(2021) Yahaya Hassan et al.   Journal of Fungi

Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations

(2021) Senna J. J. M. van Riel et al.   Journal of Fungi

Update on recurrent vulvovaginal candidiasis

(2021) Amy Borland et al.   Obstetrician & Gynaecologist

Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis

(2021) Jack D Sobel et al.   Future Microbiology

Vulval pruritus—causes, diagnosis and therapeutic approach

(2020) Linn Wölber et al.   Deutsches Arzteblatt International

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective

(2020) Diletta Rosati et al.   Microorganisms

Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome

(2020) Eline F. M. Oerlemans et al.   Scientific Reports

The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: a proof-of-concept study

(2020) Gilbert Donders et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Recurrent vulvovaginal candidiasis

(2020) Annabel Lines et al.   BMJ-British Medical Journal

Candidiasis and Mechanisms of Antifungal Resistance

(2020) Somanon Bhattacharya et al.   Antibiotics-Basel

British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019)

(2020) Guideline Development Group: Cara Saxon (Lead Author) et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Name changes for fungi of medical importance, 2018-2019

(2020) Andrew M Borman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Physician Awareness and Adherence to Clinical Practice Guidelines in the Diagnosis of Vaginitis Patients: A Retrospective Chart Review

(2020) Paul Nyirjesy et al.   Population Health Management

Prevalence and Antifungal Susceptibility Profile of Clinically Relevant Candida Species in Postmenopausal Women with Diabetes

(2020) Sarah Al Halteet et al.   Biomed Research International

Sugar Sensing and Signaling in Candida albicans and Candida glabrata

(2019) Mieke Van Ende et al.   Frontiers in Microbiology

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

(2019) Junko Yano et al.   BMC Womens Health

Influence of recurrent vulvovaginal candidiasis on quality of life issues

(2019) Eiko I. Fukazawa et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Probiotics for oral and vulvovaginal candidiasis: A review

(2019) Adele Shenoy et al.   Dermatologic Therapy

Vaginal Epithelial Cells discriminate between yeast and hyphae of C. albicans in women who are colonized with or have vaginal candidiasis

(2019) Elena Roselletti et al.   JOURNAL OF INFECTIOUS DISEASES

Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk

(2019) Monica Borghi et al.   Frontiers in Immunology

Relationship Between Human β-Defensin 2 and the Vaginal Environment

(2019) Hideko Kotani et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

(2018) Stephen R. Brand et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Is non-response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions?

(2018) Gilbert G. G. Donders et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

(2018) John E Edwards et al.   CLINICAL INFECTIOUS DISEASES

Genomes shed light on the secret life of Candida glabrata: not so asexual, not so commensal

(2018) Toni Gabaldón et al.   CURRENT GENETICS

Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis?

(2018) Gilbert G.G. Donders et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species

(2018) J. D. Sobel et al.   EXPERT OPINION ON PHARMACOTHERAPY

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

(2018) Adane Bitew et al.   BMC Womens Health

2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge

(2018) Jackie Sherrard et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Global burden of recurrent vulvovaginal candidiasis: a systematic review

(2018) David W Denning et al.   LANCET INFECTIOUS DISEASES

IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance

(2018) Giorgia Renga et al.   Frontiers in Immunology

Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism

(2017) Svitrigaile Grinceviciene et al.   MYCOSES

Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis

(2016) Yu-Xia Zhu et al.   Health and Quality of Life Outcomes

Fluconazole-Resistant Candida albicans Vulvovaginitis

(2016) Dror Marchaim et al.   OBSTETRICS AND GYNECOLOGY

Identification of novel mechanisms involved in generating localized vulvodynia pain

(2015) Megan L. Falsetta et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013)

(2015) W. Mendling et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Miconazole Nitrate Vaginal Suppository 1,200 mg versus Oral Fluconazole 150 mg in Treating Severe Vulvovaginal Candidiasis

(2015) Shangrong Fan et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

EFFECT OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON VAGINAL Candida spp. ISOLATION IN HIV-INFECTED COMPARED TO HIV-UNINFECTED WOMEN

(2015) Silvia de Souza Dantas ALCZUK et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Fluconazole Resistance Patterns in Candida Species that Colonize Women with HIV Infection

(2014) Lulu Zhang et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

Prevalence of Bacterial Vaginosis and Candida among Postmenopausal Women in the United States

(2014) J. N. Hoffmann et al.   JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES

Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis

(2014) Shangrong Fan et al.   MYCOPATHOLOGIA

Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women

(2014) Luciene Setsuko Akimoto Gunther et al.   Sao Paulo Medical Journal

Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical

(2013) Arnaldo Lopes Colombo et al.   Brazilian Journal of Infectious Diseases

Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA

(2013) Samuel Aballéa et al.   Health and Quality of Life Outcomes

Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States

(2013) Betsy Foxman et al.   Journal of Lower Genital Tract Disease

Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women

(2013) Tiina Drell et al.   PLoS One

Two unlike cousins:Candida albicansandC. glabratainfection strategies

(2012) Sascha Brunke et al.   CELLULAR MICROBIOLOGY

Regulation of Innate Immune Response toCandida albicansInfections by αMβ2-Pra1p Interaction

(2011) Dmitry A. Soloviev et al.   INFECTION AND IMMUNITY

Vulvovaginal Candidiasis in Postmenopausal Women

(2011) Gayle Fischer et al.   Journal of Lower Genital Tract Disease

Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence

(2011) Christos Iavazzo et al.   JOURNAL OF WOMENS HEALTH

From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogen

(2010) Andreas Roetzer et al.   FEMS MICROBIOLOGY LETTERS

Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights

(2010) Melissa A. Kennedy et al.   Current Infectious Disease Reports

Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy

(2009) G.G.G. Donders et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Self-elimination of risk factors for recurrent vaginal candidosis

(2009) Gilbert G. G. Donders et al.   MYCOSES

Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)

(2008) Gilbert Donders et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction

(2008) T. Weissenbacher et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis

(2008) GGG Donders et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection

(2008) J.-P. Vermitsky et al.   JOURNAL OF CLINICAL MICROBIOLOGY